Literature DB >> 15357563

Microbiological identification in cystic fibrosis patients with CFTR I1234V mutation.

A Abdul Wahab1, I A Janahi, M M Marafia, S El-Shafie.   

Abstract

Recurrent and chronic bacterial pulmonary infection is the major cause of morbidity and mortality in cystic fibrosis (CF). Over 6 months, 72 sputa or oropharyngeal samples were examined from 36 Arab Bedouin CF patients attending Hamad General Hospital, Doha, Qatar. More than 100 pathogens were isolated, mostly Haemophilus influenzae, Staphylococcus aureus and Pseudomonas aeruginosa. Unusual pathogens included Stenotrophomonas maltophilia, Acaligenes xylosoxidans and Mycobacterium abscessus. It is concluded that microbiological biodiversity in the lower airways of CF patients continues to be underestimated and that CF patients harbouring mucoid strains of P. aeruginosa are at a higher risk of acquiring more unusual organisms and probably have a worse prognosis.

Entities:  

Mesh:

Year:  2004        PMID: 15357563     DOI: 10.1093/tropej/50.4.229

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  7 in total

1.  Chelation of Membrane-Bound Cations by Extracellular DNA Activates the Type VI Secretion System in Pseudomonas aeruginosa.

Authors:  Mike Wilton; Megan J Q Wong; Le Tang; Xiaoye Liang; Richard Moore; Michael D Parkins; Shawn Lewenza; Tao G Dong
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

2.  Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis.

Authors:  Adam M Guss; Guus Roeselers; Irene L G Newton; C Robert Young; Vanja Klepac-Ceraj; Stephen Lory; Colleen M Cavanaugh
Journal:  ISME J       Date:  2010-07-15       Impact factor: 10.302

Review 3.  A Middle East systematic review and meta-analysis of prevalence and antibiotic susceptibility pattern in MRSA Staphylococcus aureus isolated from patients with cystic fibrosis.

Authors:  Yousef Nikmanesh; Afsaneh Foolady Azarnaminy; Pourya Avishan; Mohammadreza Taheri; Paniz Sabeghi; Ehsan Najibzadeh; Azad Khaledi
Journal:  J Health Popul Nutr       Date:  2022-06-28       Impact factor: 2.966

4.  Pseudomonas aeruginosa alginate promotes Burkholderia cenocepacia persistence in cystic fibrosis transmembrane conductance regulator knockout mice.

Authors:  Sangbrita S Chattoraj; Rachana Murthy; Shyamala Ganesan; Joanna B Goldberg; Ying Zhao; Marc B Hershenson; Umadevi S Sajjan
Journal:  Infect Immun       Date:  2010-01-04       Impact factor: 3.441

5.  Emergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions.

Authors:  Susana P Lopes; Nuno F Azevedo; Maria O Pereira
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

Review 6.  Approaching two decades of cystic fibrosis research in Qatar: a historical perspective and future directions.

Authors:  Samer Hammoudeh; Wessam Gadelhak; Atqah AbdulWahab; Mona Al-Langawi; Ibrahim A Janahi
Journal:  Multidiscip Respir Med       Date:  2019-10-01

7.  CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation.

Authors:  Puay-Wah Phuan; Peter M Haggie; Joseph A Tan; Amber A Rivera; Walter E Finkbeiner; Dennis W Nielson; Merlin M Thomas; Ibrahim A Janahi; Alan S Verkman
Journal:  J Cyst Fibros       Date:  2020-07-14       Impact factor: 5.482

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.